Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.02

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $10.8 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Freedom Broker Starts Holley (HLLY) at Buy
• Lockheed Martin wins $607M in defense contracts
• U.S. military launching series of strikes against Iran